Who We Are
Hankang Capital is a specialist investor in innovative biotechnology. Backed by deep industry insights and rigorous investment frameworks, we support outstanding teams developing transformative therapeutics to deliver clinical value.
We partner with entrepreneurs at critical R&D and commercialization stages to turn cutting‑edge science into real‑world industry outcomes. With a global perspective and a long‑term mindset, Hankang Capital walks alongside breakthrough innovators —continuously empowering biomedical innovation to safeguard human health.
We leverage our scientific and clinical expertise to spot differentiated innovations ahead of market consensus. As active strategic partners, we help portfolio companies mitigate risks and accelerate growth via R&D, regulatory, BD and commercial support, while connecting them to global networks and cross‑border opportunities.
